Next Article in Journal
Matrix and Backstage: Cellular Substrates for Viral Vaccines
Next Article in Special Issue
Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop
Previous Article in Journal
Generation of West Nile Virus Infectious Clones Containing Amino Acid Insertions Between Capsid and Capsid Anchor
Previous Article in Special Issue
Clinical Documentation and Data Transfer from Ebola and Marburg Virus Disease Wards in Outbreak Settings: Health Care Workers’ Experiences and Preferences
Open AccessArticle

Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism

1
Infection Biology Unit, German Primate Center, 37077 Göttingen, Germany
2
Institute of Virology, Hannover Medical School, 30625 Hannover, Germany
3
Institute of Virology, Helmholtz Center Munich, 85764 Neuherberg, Germany
4
Institute of Virology, Philipps-University-Marburg, 35043 Marburg, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Present address: Boehringer Ingelheim Veterinary Research Center GmbH & Co. KG, 30559 Hannover, Germany.
#
Present address: Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Viruses 2014, 6(4), 1654-1671; https://doi.org/10.3390/v6041654
Received: 25 November 2013 / Revised: 27 March 2014 / Accepted: 30 March 2014 / Published: 9 April 2014
(This article belongs to the Collection Advances in Ebolavirus, Marburgvirus, and Cuevavirus Research)
The host cell protein tetherin can restrict the release of enveloped viruses from infected cells. The HIV-1 protein Vpu counteracts tetherin by removing it from the site of viral budding, the plasma membrane, and this process depends on specific interactions between the transmembrane domains of Vpu and tetherin. In contrast, the glycoproteins (GPs) of two filoviruses, Ebola and Marburg virus, antagonize tetherin without reducing surface expression, and the domains in GP required for tetherin counteraction are unknown. Here, we show that filovirus GPs depend on the presence of their authentic transmembrane domains for virus-cell fusion and tetherin antagonism. However, conserved residues within the transmembrane domain were dispensable for membrane fusion and tetherin counteraction. Moreover, the insertion of the transmembrane domain into a heterologous viral GP, Lassa virus GPC, was not sufficient to confer tetherin antagonism to the recipient. Finally, mutation of conserved residues within the fusion peptide of Ebola virus GP inhibited virus-cell fusion but did not ablate tetherin counteraction, indicating that the fusion peptide and the ability of GP to drive host cell entry are not required for tetherin counteraction. These results suggest that the transmembrane domains of filoviral GPs contribute to tetherin antagonism but are not the sole determinants. View Full-Text
Keywords: tetherin; ebola; lassa; glycoprotein tetherin; ebola; lassa; glycoprotein
Show Figures

Figure 1

MDPI and ACS Style

Gnirß, K.; Fiedler, M.; Krämer-Kühl, A.; Bolduan, S.; Mittler, E.; Becker, S.; Schindler, M.; Pöhlmann, S. Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism. Viruses 2014, 6, 1654-1671.

Show more citation formats Show less citations formats

Article Access Map

1
Only visits after 24 November 2015 are recorded.
Back to TopTop